7, 8-Dihydroxyflavone improves motor performance and enhances lower motor neuronal survival in a mouse model of amyotrophic lateral sclerosis OT Korkmaz, N Aytan, I Carreras, JK Choi, NW Kowall, BG Jenkins, ... Neuroscience letters 566, 286-291, 2014 | 90 | 2014 |
Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF … OT Korkmaz, N Tunçel, M Tunçel, EM Öncü, V Şahintürk, M Çelik Journal of molecular neuroscience 41, 278-287, 2010 | 59 | 2010 |
Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum N Tunçel, OT Korkmaz, N Tekin, E Şener, F Akyüz, M Inal Journal of Molecular Neuroscience 46, 51-57, 2012 | 50 | 2012 |
A simple and sensitive LC–ESI-MS (ion trap) method for the determination of bupropion and its major metabolite, hydroxybupropion in rat plasma and brain microdialysates D Yeniceli, E Şener, OT Korkmaz, D Doğrukol-Ak, N Tuncel Talanta 84 (1), 19-26, 2011 | 39 | 2011 |
Modulation of corpus striatal neurochemistry by astrocytes and vasoactive intestinal peptide (VIP) in parkinsonian rats İH Yelkenli, E Ulupinar, OT Korkmaz, E Şener, G Kuş, Z Filiz, N Tunçel Journal of Molecular Neuroscience 59, 280-289, 2016 | 33 | 2016 |
Vasoactive intestinal peptide decreases β-amyloid accumulation and prevents brain atrophy in the 5xFAD mouse model of Alzheimer’s disease OT Korkmaz, H Ay, N Aytan, I Carreras, NW Kowall, A Dedeoglu, N Tuncel Journal of Molecular Neuroscience 68, 389-396, 2019 | 29 | 2019 |
Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats OT Korkmaz, H Ay, E Ulupınar, N Tunçel Journal of Molecular Neuroscience 48, 565-573, 2012 | 27 | 2012 |
Advantages of vasoactive intestinal peptide for the future treatment of Parkinson's disease OT Korkmaz, N Tunçel Current Pharmaceutical Design 24 (39), 4693-4701, 2018 | 25 | 2018 |
The effects of vasoactive intestinal peptide on dura mater nitric oxide levels and vessel-contraction responses in sympathectomized rats F Tore, OT Korkmaz, D Dogrukol-Ak, N Tunçel Journal of molecular neuroscience 41, 288-293, 2010 | 13 | 2010 |
Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI–LC–MS (ion trap) E Sener, OT Korkmaz, D Yeniceli, D Dogrukol-Ak, M Tuncel, N Tuncel Chromatographia 66, 31-36, 2007 | 13 | 2007 |
Determination of Ochratoxin-A in the brain microdialysates and plasma of awake, freely moving rats using ultra high performance liquid chromatography fluorescence detection method EMÖ Kaya, OT Korkmaz, DY Uğur, E Şener, AN Tunçel, M Tunçel Journal of Chromatography B 1125, 121700, 2019 | 11 | 2019 |
Can brain-derived neurotrophic factor (BDNF) mimetics be a way out for neurodegenerative diseases? OT Korkmaz Current Pharmaceutical Design 29 (4), 246-250, 2023 | 7 | 2023 |
The Effects of Carvacrol on Transient Receptor Potential (TRP) Channels in an Animal Model of Parkinson’s Disease T Akan, Y Aydın, OT Korkmaz, E Ulupınar, F Saydam Neurotoxicity Research 41 (6), 660-669, 2023 | 6 | 2023 |
Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIP OT Korkmaz, S Arkan, EM Öncü-Kaya, N Ateş, N Tunçel Neuroscience Letters 765, 136268, 2021 | 4 | 2021 |
CRITICAL ROLE OF ASTROCYTES ON STRIATAL NEURO-CHEMISTRY IN VIP TREATED PARKINSONIAN RATS N Tunçel, I Yelkenli, E Ulupinar, OT Korkmaz, E Sener, G Kus JOURNAL OF MOLECULAR NEUROSCIENCE 51, S212-S212, 2013 | 1 | 2013 |
Determination of carbamazepine and its main metabolite carbamazepine-10, 11-epoxide in rat brain microdialysate and blood using ESI-LC-MS (ion trap) E ŞENER, O KorkmaZ, D Yeniceli, D Do'grukol-Ak, M Tuncel, N Tuncel CHROMATOGRAPHIA, 2007 | 1 | 2007 |
Increased Serotonin Levels and Unchanged Glutamate and GABA Levels in Thalamic Microdialysates Despite Reduced Cell Numbers in a Valproic Acid-Induced Autism Model H Ay, E Horata, EM Öncü Kaya, OT Korkmaz Neurochemical Research 50 (1), 1-11, 2025 | | 2025 |
Vasoactive Intestinal Peptide (VIP) and its Receptors in Adipose Tissue: Implications for Cold Stress Adaptation OT Korkmaz, F Saydam, B Dalkiran, İ Değirmenci, N Tunçel Cell Biochemistry and Biophysics, 1-10, 2024 | | 2024 |
Investigation of the Neuroprotective Effect of Riluzole on Matrix Metalloproteinases in an Experimental Model of Glaucoma F Yildiz, N Sahinoglu-Keskek, IT Yilmaz, İA Candan, OT Korkmaz Journal of Current Ophthalmology 36 (2), 136-144, 2024 | | 2024 |
Vasoactive Intestinal Peptide Differentially Modulates Neurogenesis in Experimental Parkinson's Disease Models CC Meral, OT Korkmaz, N Tuncel ACTA PHYSIOLOGICA 240, 62-62, 2023 | | 2023 |